Research Analysts’ updated eps estimates for Wednesday, September 6th:

Alcoa Corp. (NYSE:AA) was upgraded by analysts at Zacks Investment Research from a hold rating to a strong-buy rating. Zacks Investment Research currently has $51.00 target price on the stock. According to Zacks, “Alcoa is a global industry leader in bauxite, alumina and aluminum products. “

AA PLC (NASDAQ:AATDF) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $2.75 price target on the stock. According to Zacks, “AA PLC offers automobile insurance and breakdown coverage. Its operating segment consists of Roadside Assistance, Insurance Services, Driving Services, Ireland and Insurance Underwriting. The company serves car manufacturers, fleet and leasing companies and insurance companies. AA PLC is based in Basingstoke, the United Kingdom. “

Allergy Therapeuti (NASDAQ:AGYTF) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Allergy Therapeutics Plc is a specialty pharmaceutical company focused on allergy vaccination. The company’s product pipeline consists of PollinexTrees(R), Pollinex Grasses + Rye(R), Skin Prick Testing, Diagnostic Products and Service. Allergy Therapeutics Plc is based in Worthing, the United Kingdom. “

Altra Industrial Motion Corp. (NASDAQ:AIMC) had its buy rating reiterated by analysts at BMO Capital Markets. They currently have a $53.00 price target on the stock.

AnaptysBio (NASDAQ:ANAB) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “AnaptysBio, Inc. is a biotechnology company. It involved in the discovery and development of therapeutic antibodies for inflammation and immuno-oncology primarily in the Unites states. AnaptysBio, Inc. is based in San Diego, California. “

ANTA SPORTS PRODUC HKD0.10 (NASDAQ:ANPDF) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $3.00 price target on the stock. According to Zacks, “ANTA Sports Products Limited designs, develops, manufactures, trades, distributes, and markets sportswear in the People’s Republic of China. The company’s products include footwear, apparel, and accessories for professionals and the general public. ANTA Sports Products Limited is headquartered in Jinjiang City, the People’s Republic of China. “

Smith (A.O.) Corporation (NYSE:AOS) had its buy rating reissued by analysts at BMO Capital Markets. BMO Capital Markets currently has a $60.00 target price on the stock.

ArQule (NASDAQ:ARQL) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “ArQule, Inc. is a biotechnology company engaged in the research and development of next-generation, small-molecule cancer therapeutics. The Company’s targeted, broad-spectrum products and research programs are focused on key biological processes that are central to cancer. ArQule’s lead clinical-stage products have been generated from two scientific platforms: Cancer Survival Protein modulation and Activated Checkpoint Therapy. The Cancer Survival Protein modulation platform has generated a clinical-stage product that mediates its effects by inhibiting the activity of a molecule known as c-Met, which plays multiple roles in cancer cell growth, survival, invasion, angiogenesis and metastasis. The ACT platform is designed to kill cancer cells selectively while sparing normal cells through direct activation of DNA damage response/checkpoint pathways. The Company’s lead ACT program, based on the E2F-1 pathway, is partnered with Roche. “

Athersys (NASDAQ:ATHX) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Athersys is a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The company’s lead product candidate, ATHX-105, is an oral, selective 5HT2c receptor agonist in Phase I clinical trials for the treatment of obesity. The company is also developing other orally active pharmaceutical product candidates for the treatment of metabolic and central nervous system disorders, utilizing proprietary technologies, including Random Activation of Gene Expression (RAGE). Athersys is developing MultiStem(r), its patented, adult-derived “off the shelf” stem cell product platform, for multiple disease indications, including damage caused by myocardial infarction, bone marrow transplantation/oncology support, ischemic stroke and other indications. “

Aviva Plc (NASDAQ:AVVIY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $15.00 target price on the stock. According to Zacks, “Aviva has established a competitive position in North America. In the US, the world’s largest savings market, Aviva is the leading provider of indexed annuity and indexed life insurance products. Its principal activity is the provision of financial products and services, focused on the following lines of business: long-term insurance and savings business, fund management and general insurance and health. The company’s business is managed on a geographic basis through a regional management structure based on four regions, U.K., Europe, North America and Asia Pacific. The four regions function as five operating segments as, due to the size of the U.K. region, it is split into two operating segments, U.K. Life and U.K. General Insurance, which undertake long term insurance and savings business and general insurance respectively. “

Anavex Life Sciences Corp. (NASDAQ:AVXL) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $5.50 price target on the stock. According to Zacks, “ANAVEX LIFE SCIENCES CORP. is an emerging biopharmaceutical company engaged in the discovery and development of novel drug targets for the treatment of cancer and neurological diseases. The company’s proprietary SIGMACEPTOR Discovery Platform involves the rational drug design of compounds that fulfill specific criteria based on unmet market needs and new scientific advances. Selected drug candidates demonstrate high, non-exclusive affinity for sigma receptors, which are involved in the modulation of multiple cellular biochemical signaling pathways. “

Banco Bilbao Vizcaya Argentaria SA (NASDAQ:BBVA) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Banco Bilbao Vizcaya is engaged in a wide variety of banking, financial and related activities in Spain. “

Boohoo.Com Plc (NASDAQ:BHOOY) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “boohoo.com plc designs, sources, markets and sells clothing, shoes and accessories through the www.boohoo.com Website. It operates primarily in the United Kingdom, Europe and internationally. The company’s brand name consists of boohooMan. boohoo.com plc is headquartered in Manchester, the United Kingdom. “

Bitauto Holdings Limited (NYSE:BITA) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Bitauto Holdings Limited is engaged in providing internet content and marketing services for automotive industry in China. Its bitauto.com and ucar.cn websites provide consumers new and used automobile pricing information, specifications, reviews and consumer feedback. The Company operates in three segments- bitauto.com business, ucar.cn business and digital marketing solutions business. Bitauto.com business provides subscription services to new automobile dealers and advertising services to dealers and automakers on bitauto.com website. Bitauto’s ucar.cn business provides listing and advertising services to used automobile dealers on ucar.cn website. The Company’s digital marketing solutions business provides automakers with digital marketing solutions, including website creation and maintenance, online public relations, online marketing campaigns and advertising agent services. Bitauto Holdings Limited is headquartered in Beijing, the People’s Republic of China. “

Bank of Commerce Holdings (NASDAQ:BOCH) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Bank of Commerce Holdings is a financial service holding company that owns Redding Bank of Commerce, Roseville Bank of Commerce, a division of Redding Bank of Commerce and Bank of Commerce Mortgage, an affiliate of Redding Bank of Commerce and Roseville Bank of Commerce. “

Rockwell Collins (NYSE:COL) was downgraded by analysts at Wolfe Research from an outperform rating to a peer perform rating.

Callon Petroleum (NYSE:CPE) had its buy rating reaffirmed by analysts at BMO Capital Markets. BMO Capital Markets currently has a $15.00 price target on the stock.

Dr Pepper Snapple Group (NYSE:DPS) had its buy rating reaffirmed by analysts at BMO Capital Markets. BMO Capital Markets currently has a $105.00 price target on the stock.

G-III Apparel Group, LTD. (NASDAQ:GIII) was upgraded by analysts at Telsey Advisory Group from a market perform rating to an outperform rating. Telsey Advisory Group currently has $36.00 price target on the stock, up from their previous price target of $27.00.

General Mills (NYSE:GIS) had its hold rating reiterated by analysts at BMO Capital Markets. They currently have a $60.00 target price on the stock.

IDEX Corporation (NYSE:IEX) had its hold rating reiterated by analysts at BMO Capital Markets. The firm currently has a $110.00 target price on the stock.

Kellogg (NYSE:K) had its hold rating reaffirmed by analysts at BMO Capital Markets. The firm currently has a $78.00 target price on the stock.

Monster Beverage Corporation (NASDAQ:MNST) had its buy rating reissued by analysts at BMO Capital Markets. They currently have a $58.00 target price on the stock.

Oil States International (NYSE:OIS) had its hold rating reiterated by analysts at BMO Capital Markets. BMO Capital Markets currently has a $24.00 target price on the stock.

Pepsico (NYSE:PEP) had its hold rating reissued by analysts at BMO Capital Markets. BMO Capital Markets currently has a $120.00 target price on the stock.

Pentair PLC. (NYSE:PNR) had its hold rating reissued by analysts at BMO Capital Markets. The firm currently has a $70.00 price target on the stock.

Royal Gold (NASDAQ:RGLD) (TSE:RGL) had its buy rating reissued by analysts at BMO Capital Markets. They currently have a $95.00 target price on the stock.

Schlumberger N.V. (NYSE:SLB) had its buy rating reiterated by analysts at BMO Capital Markets. BMO Capital Markets currently has a $74.00 price target on the stock.

Teleflex (NYSE:TFX) was upgraded by analysts at Morgan Stanley from an equal weight rating to an overweight rating.

Vuzix Corporation (NASDAQ:VUZI) had its buy rating reiterated by analysts at Maxim Group. The firm currently has a $11.00 target price on the stock. The analysts wrote, “Vuzix announced it has partnered with software developer Cyber Eyez (private) and the Wounded Warrior Program to be the exclusive provider supplying American veterans that have limited eye sight or blindness, with smart glasses.””

Silver Wheaton Corp (NYSE:WPM) had its buy rating reissued by analysts at BMO Capital Markets. The firm currently has a $28.00 target price on the stock.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.